Effect of hemodialysis on total body clearance of chloramphenicol
- PMID: 7405936
Effect of hemodialysis on total body clearance of chloramphenicol
Abstract
The effect of hemodialysis on the total body clearance (ClTB) of chloramphenicol was studied in two patients with renal failure and hepatic dysfunction. Chloramphenicol sodium succinate was administered intravenously eight hours before dialysis in doses of 20 and 26.1 mg/kg/day to Patients 1 and 2, respectively. Serum samples were taken at 48 hours after initiation of the drug, 2.5 hours after the last dose and 5 minutes into dialysis for Patient 1, and before dosing and at 0.5, 1, 2, 4, 6, 8 and 11 hours after dosing for Patient 2. Serum levels of chloramphenicol were measured by high-performance liquid chromatography. Chloramphenicol ClTB values on dialysis (162.2 and 118 ml/min for Patients 1 and 2, respectively) were 58% and 72% higher than off-dialysis ClTB values (102.9 and 69 ml/min) for Patients 1 and 2, respectively. Dialysis extraction ratios for chloramphenicol were 0.52 and 0.31 for Patients 1 and 2, respectively. Although the increased clearance of chloramphenicol that occurred during dialysis may be important only in patients with hepatic dysfunction, it is recommended that the normal maintenance dose of the drug be administered after dialysis to avoid the possibility of increased clearance.
Similar articles
-
Chloramphenicol hemodialysis clearance.Ther Drug Monit. 1980;2(4):351-4. Ther Drug Monit. 1980. PMID: 7222188
-
Hemodialysis of mefenamic acid in uremic patients.Am J Hosp Pharm. 1980 Jul;37(7):956-8. Am J Hosp Pharm. 1980. PMID: 7395889
-
Disposition of didanosine in HIV-seropositive patients with normal renal function or chronic renal failure: influence of hemodialysis and continuous ambulatory peritoneal dialysis.Clin Pharmacol Ther. 1996 Nov;60(5):535-42. doi: 10.1016/S0009-9236(96)90149-6. Clin Pharmacol Ther. 1996. PMID: 8941026 Clinical Trial.
-
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.Dan Med Bull. 2008 Nov;55(4):186-210. Dan Med Bull. 2008. PMID: 19232159 Review.
-
Early adventures in drug metabolism. 3. Chloramphenicol.Ther Drug Monit. 1987 Sep;9(3):320-30. doi: 10.1097/00007691-198709000-00012. Ther Drug Monit. 1987. PMID: 3313827 Review.
Cited by
-
Clinical pharmacokinetics of chloramphenicol and chloramphenicol succinate.Clin Pharmacokinet. 1984 May-Jun;9(3):222-38. doi: 10.2165/00003088-198409030-00004. Clin Pharmacokinet. 1984. PMID: 6375931 Review.
-
Drug therapy in patients undergoing haemodialysis. Clinical pharmacokinetic considerations.Clin Pharmacokinet. 1984 Jan-Feb;9(1):42-66. doi: 10.2165/00003088-198409010-00003. Clin Pharmacokinet. 1984. PMID: 6362952 Review.
-
Clinical pharmacokinetics of antibiotics in patients with impaired renal function.Clin Pharmacokinet. 1992 Mar;22(3):169-210. doi: 10.2165/00003088-199222030-00002. Clin Pharmacokinet. 1992. PMID: 1559311 Review.
-
Guide to drug dosage in renal failure.Clin Pharmacokinet. 1988 Nov;15(5):326-54. doi: 10.2165/00003088-198815050-00005. Clin Pharmacokinet. 1988. PMID: 3060292 Review. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Medical